155 related articles for article (PubMed ID: 3200248)
41. Apparent heterogeneity of cardiac A1 adenosine receptors as revealed by radioligand binding experiments on N-ethylmaleimide-treated membranes.
Leung E; Jacobson KA; Green RD
Naunyn Schmiedebergs Arch Pharmacol; 1991 Dec; 344(6):639-44. PubMed ID: 1775196
[TBL] [Abstract][Full Text] [Related]
42. Characterization of cardiac A1 adenosine receptors by ligand binding and photoaffinity labeling.
Leung E; Kwatra MM; Hosey MM; Green RD
J Pharmacol Exp Ther; 1988 Mar; 244(3):1150-6. PubMed ID: 3252029
[TBL] [Abstract][Full Text] [Related]
43. Autoradiographic localization of mouse brain adenosine receptors with an antagonist ([3H]xanthine amine congener) ligand probe.
Deckert J; Morgan PF; Bisserbe JC; Jacobson KA; Kirk KL; Daly JW; Marangos PJ
Neurosci Lett; 1988 Mar; 86(2):121-6. PubMed ID: 3368115
[TBL] [Abstract][Full Text] [Related]
44. [125I]4-aminobenzyl-5'-N-methylcarboxamidoadenosine (125I)AB-MECA) labels multiple adenosine receptor subtypes in rat brain.
Shearman LP; Weaver DR
Brain Res; 1997 Jan; 745(1-2):10-20. PubMed ID: 9037389
[TBL] [Abstract][Full Text] [Related]
45. Chemical modification and irreversible inhibition of striatal A2a adenosine receptors.
Jacobson KA; Stiles GL; Ji XD
Mol Pharmacol; 1992 Jul; 42(1):123-33. PubMed ID: 1635550
[TBL] [Abstract][Full Text] [Related]
46. Molecular cloning and functional expression of a sheep A3 adenosine receptor with widespread tissue distribution.
Linden J; Taylor HE; Robeva AS; Tucker AL; Stehle JH; Rivkees SA; Fink JS; Reppert SM
Mol Pharmacol; 1993 Sep; 44(3):524-32. PubMed ID: 8396714
[TBL] [Abstract][Full Text] [Related]
47. Co-purification of A1 adenosine receptors and guanine nucleotide-binding proteins from bovine brain.
Munshi R; Linden J
J Biol Chem; 1989 Sep; 264(25):14853-9. PubMed ID: 2504712
[TBL] [Abstract][Full Text] [Related]
48. 125I-4-aminobenzyl-5'-N-methylcarboxamidoadenosine, a high affinity radioligand for the rat A3 adenosine receptor.
Olah ME; Gallo-Rodriguez C; Jacobson KA; Stiles GL
Mol Pharmacol; 1994 May; 45(5):978-82. PubMed ID: 8190112
[TBL] [Abstract][Full Text] [Related]
49. Possible involvement of pertussis toxin-sensitive G proteins and D2 dopamine receptors in the A1 adenosine receptor-adenylate cyclase system in rat cerebral cortex.
Murayama T; Itahashi Y; Nomura Y
J Neurochem; 1990 Nov; 55(5):1631-8. PubMed ID: 2145396
[TBL] [Abstract][Full Text] [Related]
50. 8-Polycycloalkyl-1,3-dipropylxanthines as potent and selective antagonists for A1-adenosine receptors.
Shimada J; Suzuki F; Nonaka H; Ishii A
J Med Chem; 1992 Mar; 35(5):924-30. PubMed ID: 1548682
[TBL] [Abstract][Full Text] [Related]
51. Affinity chromatography of A1 adenosine receptors of rat brain membranes.
Nakata H
Mol Pharmacol; 1989 Jun; 35(6):780-6. PubMed ID: 2733695
[TBL] [Abstract][Full Text] [Related]
52. Photoaffinity cross-linked A1 adenosine receptor-binding subunits. Homologous glycoprotein expression by different tissues.
Stiles GL
J Biol Chem; 1986 Aug; 261(23):10839-43. PubMed ID: 3015944
[TBL] [Abstract][Full Text] [Related]
53. 2-Chloro-N6-[3H]cyclopentyladenosine ([3H]CCPA)--a high affinity agonist radioligand for A1 adenosine receptors.
Klotz KN; Lohse MJ; Schwabe U; Cristalli G; Vittori S; Grifantini M
Naunyn Schmiedebergs Arch Pharmacol; 1989 Dec; 340(6):679-83. PubMed ID: 2615857
[TBL] [Abstract][Full Text] [Related]
54. 7-Deaza-2-phenyladenines: structure-activity relationships of potent A1 selective adenosine receptor antagonists.
Müller CE; Hide I; Daly JW; Rothenhäusler K; Eger K
J Med Chem; 1990 Oct; 33(10):2822-8. PubMed ID: 2213835
[TBL] [Abstract][Full Text] [Related]
55. Demonstration of distinct agonist and antagonist conformations of the A1 adenosine receptor.
Barrington WW; Jacobson KA; Stiles GL
J Biol Chem; 1989 Aug; 264(22):13157-64. PubMed ID: 2753906
[TBL] [Abstract][Full Text] [Related]
56. Persistent activation by and receptor reserve for an irreversible A1-adenosine receptor agonist in DDT1 MF-2 cells and in guinea pig heart.
Zhang J; Belardinelli L; Jacobson KA; Otero DH; Baker SP
Mol Pharmacol; 1997 Sep; 52(3):491-8. PubMed ID: 9281612
[TBL] [Abstract][Full Text] [Related]
57. Binding of the radioligand [3H]-SCH 58261, a new non-xanthine A2A adenosine receptor antagonist, to rat striatal membranes.
Zocchi C; Ongini E; Ferrara S; Baraldi PG; Dionisotti S
Br J Pharmacol; 1996 Apr; 117(7):1381-6. PubMed ID: 8730729
[TBL] [Abstract][Full Text] [Related]
58. Species differences in brain adenosine A1 receptor pharmacology revealed by use of xanthine and pyrazolopyridine based antagonists.
Maemoto T; Finlayson K; Olverman HJ; Akahane A; Horton RW; Butcher SP
Br J Pharmacol; 1997 Nov; 122(6):1202-8. PubMed ID: 9401787
[TBL] [Abstract][Full Text] [Related]
59. Characterization of adenosine A1 receptors in intact DDT1 MF-2 smooth muscle cells.
Gerwins P; Nordstedt C; Fredholm BB
Mol Pharmacol; 1990 Nov; 38(5):660-6. PubMed ID: 2172773
[TBL] [Abstract][Full Text] [Related]
60. Evidence for high-affinity binding sites for the adenosine A2A receptor agonist [3H] CGS 21680 in the rat hippocampus and cerebral cortex that are different from striatal A2A receptors.
Cunha RA; Johansson B; Constantino MD; Sebastião AM; Fredholm BB
Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):261-71. PubMed ID: 8692280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
